Key statistics
As of last trade, Novavax Inc (0A3S:LSE) traded at 13.48, 281.87% above the 52 week low of 3.53 set on Feb 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.90 |
---|---|
High | 13.48 |
Low | 13.48 |
Bid | -- |
Offer | -- |
Previous close | 11.90 |
Average volume | 243.10k |
---|---|
Shares outstanding | 160.09m |
Free float | 153.08m |
P/E (TTM) | -- |
Market cap | 2.18bn USD |
EPS (TTM) | -2.76 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 14:32 BST.
More ▼
Press releases
- Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
- Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.
- Novavax to Participate in Upcoming September Conferences
- Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
- Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights
- Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024
More ▼